CN104946688B - A kind of method for cutting off screening label and application - Google Patents
A kind of method for cutting off screening label and application Download PDFInfo
- Publication number
- CN104946688B CN104946688B CN201510275632.3A CN201510275632A CN104946688B CN 104946688 B CN104946688 B CN 104946688B CN 201510275632 A CN201510275632 A CN 201510275632A CN 104946688 B CN104946688 B CN 104946688B
- Authority
- CN
- China
- Prior art keywords
- pyrg
- loxp
- screening
- label
- pyrg1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of method for cutting off screening label and application, belong to gene engineering technology field.The present invention be the recombinant bacterium that pyrG screening label of the both sides with loxP sequences in the same direction is incorporated using on chromosome to go out bacterium germination, bacterial strain use pyrG screening label progress genetic transformations as going out bacterium germination again using pyrG screening label of the site-specific recombination system excision between two loxP sequences.The excision of screening label can be carried out using the method for the present invention, makes screening label reusable edible, genetic modification is no longer limited by screening label deficiency, and the genetic modification for polygenes, more sites provides support.
Description
Technical field
The present invention relates to a kind of method for cutting off screening label and application, belong to gene engineering technology field.
Background technology
Aspergillus terreus is a kind of important filamentous fungi, can produce a variety of valuable compounds therefroms, including organic acid, enzyme
Class, lipid and biologically active secondary metabolite.Wherein itaconic acid and Lovastatin has been carried out industrialized production,
With very big market.With the continuous development of molecular biology, production bacterial strain is transformed by metabolic engineering, improves mesh
The production level of product is marked, is had very important significance.
With the continuous progress of Protocols in Molecular Biology, the genetic engineering transformation of functional genomics and bacterial strain becomes to get over
Come more important.In recent years, a large amount of groups learn the continuous announcement of data, and functional genomics research and genetic engineering transformation often relate to
And to polygenes, more sites, but also a variety of research strategies can be used.And it is required during genetic manipulation to screen label
A kind of critical elements, exogenous DNA needs to be incorporated on genome together with screening label, then again by screening the phenotype of label
It is screened out.And available screening label is considerably less in Aspergillus terreus, it can not meet that carrying out heredity to polygenes, multidigit point changes
The demand made.Site-specific recombination system is a kind of important molecular genetic manipulation instrument, its principle is that recombinase identifies simultaneously
It is attached on the target site with special DNA sequence dna, is catalyzed recombining reaction so that the DNA fragmentation between target site is picked
Remove.Based on this, the excision of screening label is being successfully applied to.Common site-specific recombination system has Cre/loxP systems
System, β-rec/six systems and Flp/FRT systems, but need in traditional application process whole with shuttle plasmid form or genome
Conjunction form imports recombinase Expression element into cell, gives expression to recombinase in the cell by modes such as inductions, and act on
Recognition site cuts off screening label.PyrG (orotidine -5- phosphate decarboxylase genes) is that one kind is lacked with uracil nutrition
The nutrition selection type label that the collocation of property bacterial strain uses is fallen into, bidirectional screening work(is had as the conversion system of screening label based on pyrG
The feature of energy, screening label presence or absence can be screened by corresponding screening and culturing medium.Therefore collocation site-specific
Property recombination system use, can cause screen label rejecting it is more efficient, easy.
The content of the invention
To solve during Aspergillus terreus genetic manipulation screening number of labels can be used limited, cause gene targeting native bent
Using the technical problem being restricted in mould field of genetic modification, the present invention provides a kind of method for cutting off screening label, make
Label reusable edible is screened, genetic modification is no longer limited by screening label deficiency, and the technical solution taken is as follows：
It is an object of the invention to provide a kind of method for cutting off screening label, this method is to be incorporated on chromosome
The recombinant bacterium of pyrG screening labels is bacterium germination, enables bacterial strain again using site-specific recombination system excision pyrG screening labels
It is secondary to be used as bacterium germination to use pyrG screening labels to carry out genetic transformation.
Preferably, it is described go out bacterium germination, be Aspergillus terreus (Aspergillus terreus).
It is highly preferred that it is described go out bacterium germination, to have knocked out the Aspergillus terreus of ku80 genes or lig4 genes.
Preferably, the recombinant bacterium of pyrG screening labels is incorporated on the chromosome, the both sides of pyrG screening labels carry
LoxP sequences in the same direction.
Preferably, the pyrG screenings label comes from aspergillus, it is highly preferred that deriving from aspergillus niger.
Preferably, the site-specific recombination system, is Cre/loxP site-specific recombination systems；The excision
PyrG screens label, is to cut off the screening label pyrG that both sides carry loxP sequences in the same direction.
Preferably, the Cre/loxP site-specific recombination systems, the dosage of Cre recombinases is 2-9U.
The step of the method, is as follows：
1) using the uracil auxotrophy Aspergillus terreus of pyrG gene delections as recipient bacterium, to come from the both ends band of aspergillus niger
The pyrG gene expression elements loxP-pyrG1-loxP for having loxP sites in the same direction carries out covering experiment as screening label, obtains
It is integrated with the recombinant bacterium of loxP-pyrG1-loxP screening labels；
2) preparation process 1) described in recombinant bacterium protoplast, led using DNA as assistant carrier into protoplasm somatocyte
The Cre recombinases for entering 2-9U carry out screening label excision, and loxP- is screened by way of screening uracil auxotrophy
The recombinant bacterium that pyrG1-loxP selection markers are removed.
Preferably, the method comprises the following steps that：
1) the ku80 genes and pyrG genes of Aspergillus terreus CICC 40205 is knocked out respectively, builds uracil auxotrophy weight
Group bacterium At- Δ ku80- Δs pyrG；
2) using the pyrG gene expression elements pyrG1 of aspergillus niger Co827 as screening label, by way of molecular cloning
Both sides add loxP sequences in the same direction, obtain the pyrG selection markers loxP-pyrG1-loxP that both ends carry loxP sites in the same direction,
Using the uracil auxotrophy recombinant bacterium At- Δs ku80- Δs pyrG constructed by step 1) as recipient bacterium, with loxP-pyrG1-
LoxP carries out covering experiment for screening label, obtains the recombinant bacterium At- Δs for being integrated with loxP-pyrG1-loxP screening labels
ku80-pyrG1-loxP；
3) preparation process 2) gained recombinant bacterium At- Δs ku80-pyrG1-loxP protoplast, using DNA as assistant carrier
The Cre recombinases that 2-9U is imported into protoplasm somatocyte carry out screening label excision, by screening uracil auxotrophy
Mode screen the recombinant bacterium that loxP-pyrG1-loxP selection markers are removed.
The either method is used to prepare the restructuring that may be repeated genetic transformation operation from screening number of labels limitation
Bacterium.
The recombinant bacterium prepared using the either method is also within protection scope of the present invention.
Preferably, the method comprises the following steps that：
1) using the genome of Aspergillus terreus CICC40205 as template, with the core as shown in SEQ ID NO.12-SEQ ID NO.13
Nucleotide sequence is primer, expands the upstream sequence U-pyrG of pyrG genes；Again using the genome of Aspergillus terreus CICC40205 as mould
Plate, is arranged as primer with the nucleotides sequence as shown in SEQ ID NO.14-SEQ ID NO.15, expands the downstream sequence D- of pyrG genes
pyrG；Fusion DNA vaccine fusion upstream sequence U-pyrG and downstream sequence D-pyrG is recycled, using the sequence of fusion product as template,
The target practice for going out pyrG genes by PCR amplification for primer is arranged with the nucleotides sequence as shown in SEQ ID NO.16-SEQ ID NO.17
Element pyrG-KO, then preparation process 1) gained recombinant bacterium At- Δs ku80 protoplast, then the target practice element by pyrG genes
PyrG-KO is transformed into protoplast, and the uracil auxotrophy bacterial strain that pyrG genes are knocked is obtained after culture is screened
At-Δku80-ΔpyrG；
2) the artificial synthesized DNA fragmentation for carrying two loxP sequence sites in the same direction, its nucleotide sequence such as SEQ ID are passed through
Shown in NO.1, then the DNA fragmentation is cloned on carrier pUC57simple, obtains carrier PalcA-syn；With aspergillus niger Co827
Genome is template, is arranged as primer with the nucleotides sequence as shown in SEQ ID NO.18-SEQ ID NO.19, is gone out by PCR amplification
The Expression element of aspergillus niger pyrG genes, carrier PalcA- is cloned into as screening label pyrG1, then by screening label pyrG1
On syn, plasmid pXH103 is obtained, obtains the pyrG1 that the both sides as shown in SEQ ID NO.26 carry loxP site sequences in the same direction
Screen label loxP-pyrG-loxP；Again using pSGF957 as template, with the core as shown in SEQ ID NO.20-SEQ ID NO.21
Nucleotide sequence is primer, goes out NDA fragment gfp-TtrpC fragments by PCR amplification, then gfp-TtrpC fragments are connected to plasmid
On pXH103, plasmid pXH104 is obtained；Again using Aspergillus terreus CICC40205 genomes as template, with such as SEQ ID NO.22-SEQ
Nucleotides sequence shown in ID NO.23 is classified as primer, goes out ku80 downstream of gene homology arm fragments, then going out amplification by PCR amplification
Ku80 downstream of gene homology arm fragments are connected on plasmid pXH104, obtain plasmid pXH105；Again with Aspergillus terreus CICC40205 bases
Because group is template, is arranged as primer with the nucleotides sequence as shown in SEQ ID NO.24-SEQ ID NO.25, gone out by PCR amplification
Ku80 upstream region of gene homology arm fragments, then the ku80 upstream region of gene homology arm fragments that go out of amplification are connected on plasmid pXH105,
Obtain plasmid pXH106；Finally again using plasmid pXH106 as template, using sequence shown in SEQ ID NO.8 and SEQ ID NO.10 as
Primer amplification goes out to practice shooting element ku80-pyrG1-gfp；Target practice element ku80-pyrG1-gfp is transformed into obtained by step 2) again
In uracil auxotrophy strains A t- Δ ku80- Δs pyrG, obtained after culture is screened and carry loxP-pyrG1-loxP
Recombinant bacterium At- Δs ku80-pyrG1-loxP；Uracil auxotrophy recombinant bacterium and pyrG are based on so as to prove to be successfully established
Genetic transformation system of the gene as screening label.
3) preparation process 3) gained recombinant bacterium At- Δs ku80-pyrG1-loxP protoplast, to 100 μ prepared
L concentration is 1082U Cre recombinases, 1 μ g pyrG1 fragments and 10 μ L 40% are added in the protoplast solution of a/mL
PEG4000, after mixing ice bath 30min, add 1ml PSTC solution after being incubated 30min at 30 DEG C, after incubation with
Containing 1.2M sorbierites, it is poured into after the top agar culture medium mixing of 4g/L agaroses and 2mM uridines containing 1.2M
In the CD regeneration screening and culturing medium tablets of sorbierite, 1g/L 5- fluororotic acids and 10mM uridines, at 30 DEG C, dark bar
6-10d is cultivated under part, after culture picking transformant be inoculated on CDFU tablets cultivated at 32 DEG C carry out within 5-7 days passing on it is pure
Change, after passage purifies 3-5 times, obtain the uracil auxotrophy recombinant bacterium At- Δs ku80- that pyrG1 screening labels are removed
ΔpyrG1-loxP；Recycled so as to fulfill screening label, break through genetic modification and limited by screening number of labels, can be with
The genetic transformation based on pyrG1 screening labels is carried out again.
Expression element：The DNA fragmentation of target gene transcriptional expression, including promoter, gene can be effectively driven in the cell
Code area and terminator.
Beneficial effect of the present invention：
Screening label cutting method provided by the invention, it is simple, low to genetic modification component requirements, suitable with operating process
With property it is high the advantages that, including autonomous replication type filamentous fungi plasmid need not be built, it is not necessary to build the expression member of Cre recombinases
Part, it is not necessary to the Expression element of Cre recombinases is directed into recipient cell, does not also have Cre recombinase Expression elements into the cell
Need removal etc..Therefore, the minimizing technology for screening label is simple and practicable.
The present invention is by importing Cre recombinases into Aspergillus terreus protoplasm somatocyte, based on Cre/loxP site-specifics
Property recombination system excision integrate the screening label that both sides on chromosome carry loxP sequences in the same direction, realize screening selection markers
Efficient excision, so as to establish, a homologous recombination is efficient, transformation is beaten from the high efficiency gene of screening number of labels limitation
Target platform.
The present invention realizes the excision of screening label in Aspergillus terreus by site-specific recombination system first, and is logical
Cross and Cre recombinases are introduced directly into the excision for carrying out screening label into the cell, the screening label used can bidirectional screening
PyrG genes, process are relatively easy, it is not necessary to build recombinase gene expression element, it is not necessary to Aspergillus terreus autonomously replicating plasmid and
Inducible promoter, it is not necessary to undergo plasmid loss process.The present embodiments relate to the transformation system based on pyrG genes
In, when uracil auxotrophy bacterial strain, obtains by way of pyrG is knocked out completely, the bacterial strain obtained relative to method of mutagenesis
For genetic stability it is more preferable.Selenate is needed in the screening system of sC screening labels as screening medicine, and selenate makes
There is security risk to experimenter during, be subject to control as poisonous drugs, purchase is very difficult, in filamentous fungi at present
The genetic transformation system based on sC has only been successfully established in aspergillus oryzae；Nitrate reductase niaD screens the screening system of label
In also to use the chlorate of high concentration, screening and culturing medium preparation process trouble, and niaD auxotrophic strains is spontaneous
It is high to reply probability, false positive is high in screening process；In contrast, pyrG selection markers screening process is simple, 5 fluorine of medicine being related to
The easily purchase and cheap of orotic acid, uracil or uridylic acid.But it is not all to be successfully established to be based on pyrG in all species
The conversion system of label is screened, and when establishing the genetic transformation system, also difficulty differs the different strains in same species,
Such as the genetic transformation system has been successfully established in several Aspergillus oryzae bacterial strains, but researcher is had found in many meter Qu
The defects of pyrG gene complete deactivations can not be obtained in trichoderma strain type bacterial strain, so that the genetic transformation system can not be established.
Brief description of the drawings
Fig. 1 is the schematic diagram for knocking out the target practice element of ku80 genes and its homologous recombination knockout ku80 genes occurring；
(F1 is primer Uku80-F, and F2 is primer Cku80-F, and F3 is primer PtrA-F, and F4 is primer ptrA-F171, R1
It is primer Dku80-R, R2 is primer Cku80-R, and R3 is primer ptrA-R, and R4 is primer ptrA-R744, and F5 is primer ku80-
Probe-F, R5 are primer ku80-probe-R).
Fig. 2 obtains the Genomic PCR verification result figure of transformant for knockout ku80 genes；
(figure A is primer ptrA-F/ptrA-R (F3/R3) verification result, and figure B is primer Uku80-F/ptrA-R (F1/R3)
Verification result；Figure C is primer ptrA-F/Dku80-R (F3/R1) verification result, and figure D is primer ku80-probe-F/ku80-
Probe-R (F5/R5) verification result；M is 1kb DNA ladder (TAKARA), and M2 is 200bp DNA ladder
(TAKARA), C is that CICC40205 wild-type strains are used as control, and 1-4 is is obtained transformant).
Fig. 3 is knockout Aspergillus terreus pyrG gene principle schematics；
(wherein, pdc is gene to be knocked out, and Up is upstream homology arm U-pyrG, and Down is downstream homology arm D-pyrG, arrow
Head is design of primers site).
Fig. 4 is the Genomic PCR verification result for knocking out transformant obtained by Aspergillus terreus pyrG genes；
(it is primer hph-F/DpyrG-R verification results wherein, to scheme A, and figure B is primer C-F4/C-R verification results, and figure C is
Primer S-pyrG-F/S-pyrG-R verification results；M is 200bp DNA ladder (TAKARA), and Δ ku80 is engineered strain At-
Δ ku80 obtains transformant as control, 1#, 2# for knockout pyrG genes).
Fig. 5 is the structure diagram of plasmid PalcA-syn.
Fig. 6 for covering element ku80-pyrG1-gfp and its with ku80 sites site-directed integration principle schematic；
(wherein, ku80-UP, ku80-Dw are respectively the upstream and downstream homology arm of ku80 genes, and pyrG1 is as selection markers
Come from aspergillus niger pyrG gene expression elements (including promoter, pyrG genes and terminator), arrow is design of primers position
Point).
Fig. 7 is obtained by ku80-pyrG1-gfp elements covering uracil auxotrophy strains A t- Δ ku80- Δs pyrG
The Genomic PCR verification result of transformant；
(it is primer Uku80-F/pyrG1-R verification results wherein, to scheme A, and figure B is primer pyrG1-F/pyrG1-R verification knots
Fruit, figure C are primer pyrG1-F/TtrpC-R verification results, and figure D is primer pyrG1-F/Dku80-R verification results；M is 1kb
DNA ladder (TAKARA), M2 are 200bp DNA ladder (TAKARA), and C is that engineered strain At- Δ ku80- Δs pyrG makees
For control, 1-6 is tested by covering and is obtained transformant).
Fig. 8 is the Genomic PCR proof diagram for being introduced directly into transformant obtained by Cre recombinases excision pyrG1 selection markers；
(M is 1kb DNA ladder (TAKARA), and C is engineered strain At- Δs ku80-pyrG1-loxP as control, 1-
8 are obtained transformant by covering experiment).
Fig. 9 is the DNA sequencing result for having cut off pyrG1 screening label engineered strain At- Δ ku80- Δs pyrG1-loxP；
(wherein, ku80-UP is ku80 upstream region of gene homology arms, and loxP is the loxP sequences of Cre recombinase specific recognitions
Row, PalcA is PalcA promoter sequences, and pyrG1 sheets are located at ku80-UP in engineered strain At- Δs ku80-pyrG1-loxP
Between PalcA sequences).
Embodiment
With reference to specific embodiment, the present invention will be further described, but the present invention should not be limited by the examples.
Material therefor, reagent, instrument and method in following embodiments, are the routine in this area without specified otherwise
Material, reagent, instrument and method, can be obtained by commercial channel.
Plasmid extraction uses OMEGA companies Plasmid Mini Kit I kits (D6942-01), DNA pieces in the present invention
Duan Huishou is to use OMEGA companies Cycle-Pure Kit kits (D6492-01), and gel recycling is to use OMEGA companies
Gel Extraction Kit kits (D2500-01).
The composition of CD tablets is：3g/L NaNO3, 2g/L KCl, 1g/L KH2PO4, 0.5g/L MgSO4·7H2O,
0.02g/L FeSO4·7H2O, 10g/L glucose.
IPM fluid nutrient mediums：60g L-1Glucose, 2g L-1NH4NO3, 20mg L-1NH4HPO4, 20mg L-1FeSO4,
0.4g L-1MgSO4, 4.4mg L-1ZnSO4, 0.5g/L corn pulps, pH 3.5.
The structure of embodiment 1 knocks out the NHEJ approach missing gene engineered strain At- Δs ku80 of ku80 genes
1.1 structure ku80 target practice elements
According to Aspergillus terreus NIH2624 genome databases announce information design primer Uku80-F (5 '-
gtcgtagctcttcttgccatc-3’)、Uku80-R(5’-
aatgggatcccgtaatcaattgccctcaatcaccatctcccttatc-3’)、Dku80-F(5’-
caagagcggctcatcgtcaccccattccggcctcgatgtggatgc-3’)、Dku80-R(5’-
Tccacgcggccatcaccgagc-3 '), using the genome of Aspergillus terreus bacterial strain CICC40205 as template, it is polymerize using pfu DNA
Enzyme (Fermentas, Catalog No.:EP0501 PCR amplification) is carried out, acquisition can be expanded with primer Uku80-F/Uku80-R
The upstream sequence U-ku80 for the ku80 that size is about 1.5kb, can expand acquisition size with primer Dku80-F/Dku80-R is
The downstream sequence D-ku80 of the ku80 of 1.5kb.With plasmid pPTR II (TAKARA, Catalog No.:3621) it is template, with
PtrA-F (5 '-gggcaattgattacgggatc-3 ') and ptrA-R (5 '-atggggtgacgatgagccgc-3 '), which is used as, to be drawn
Thing amplification obtains the ptrA fragments that size is about 2.0kb, is detected through 1.0% agarose gel electrophoresis and be tapped and recovered pure
Change.U-ku80 fragments, D-ku80 are merged with ptrA fragments with the method for fusion DNA vaccine, and made with the product of the fusion DNA vaccine
For template, with Cku80-F (5 '-gggtttctagaagtcacatc-3 ') and ptrA-R744 (5 '-
Atggcccatcgtgaccagtggtac-3 ') obtain the ku80 that size is about 3.0kb as primer amplification and knock out element ku80-
A, with Cku80-R (5 '-atcaccgaccctacgctgtg-3 ') and ptrA-F171 (5 '-
Ggtctctcgtgccatgaccagacg-3 ') obtain the ku80 that size is about 2.6kb as primer amplification and knock out element ku80-
B, such as Fig. 1.
It is prepared by 1.2 protoplasts
By the spore inoculating of Aspergillus terreus CICC40205 into 50mL liquid IPM culture mediums, it is about 10 to make spore concentration7A/
ML, in 200rmp, 32 DEG C of culture 12-18h.It is collected by filtration the mycelia grown with sterile 500 mesh nylon cloth of individual layer, and with sterilizing
0.6M MgSO4Solution flushes three times, and press dry and is placed in sterile 50ml triangular flasks；By 1g mycelia is weighed, 10ml enzymes are added
Liquid is solved, in 30 DEG C, 60rpm processing 1-3h.Enzymolysis liquid component is：0.8% cellulase (Sigma, Catalog No.：
C1184), 0.8% lyases (Sigma, Catalog NO.：L1412), 0.4% glusulase (gives birth to work, Catalog No. in Shanghai：
SB0870)、0.6M MgSO4, via 0.22 μm of sterilizing filter filtration sterilization.By the mixed liquor after above-mentioned enzymolysis first with 8 layers
Lens wiping paper filters, and collects filtrate.4 DEG C are collected by centrifugation protoplast, washed once with precooling 1.0M sorbitol solutions, then use precooling
STC (STC is 1.0M sorbierites, 50mM TrisHCl-pH 8.0,50mM CaCl2) washed once, finally plasm
Weight is suspended from the STC of precooling, and protoplast concentration is adjusted to 5 × 10 with STC7A/mL, obtains protoplast suspension.
1.3 protoplast transformation
Add the ku80-A fragments (about 2 μ g) of 5 μ l and the ku80-B of 5 μ l at the same time into the 150 above-mentioned protoplast suspensions of μ l
Fragment (about 1.5 μ g), adds 50 μ l PSTC, gently mixes, ice bath 30min.1mL PSTC are added, room temperature is placed after mixing
20min；Then with being poured into after 15mL top-layer agars (CD+1.2M sorbierite+4g/L agaroses, 48 DEG C of insulations after sterilizing) mixing
On 5 pieces of regeneration screening and culturing medium tablet CDSP (CD tablet+1.2M sorbierite+0.1mg/L pyrithiamines), in 30 DEG C, dark bar
Cultivated 5 days under part.
The screening and verification of 1.4 transformants
There to be pyrithiamine resistant transformants to be forwarded on screening flat board CDP (CD tablet+0.1mg/L pyrroles from tablet
Pyridine thiamines), carry out passage purifying within 5 days in 32 DEG C of cultures, this passage purification experiment is repeated twice.Random 4 plants of transformants of picking in
Cultivated in IPM fluid nutrient mediums, collect mycelia extraction genome, primer sites have carried out Genomic PCR with reference to shown in Fig. 1
Verification.As shown in Figure 2 A, PCR detections are carried out by primer pair of F3/R3, transformant has all amplified the ptrA mesh of size about 2kb
Band, and starting strain Aspergillus terreus CICC40205 does not have the band, this illustrates to incorporate in this 4 transformants complete
PtrA selection markers.As shown in Fig. 2 B, 2C, PCR detections are carried out respectively with primer pair F1/R3 and primer pair F3/R1, as a result 2#,
3# transformants have all amplified the purpose band that size is about 3.5kb respectively, other transformants are then without band, this explanation 2#, 3#
Transformant is that there occurs homologous recombination on ku80 sites for target practice element.As shown in Figure 2 D, with design in ku80 gene internals
Primer pair ku80-probe-F (5 '-gcactctcgaacaggcagtgtc-3 ') and ku80-probe-R (5 '-
Atcagtcgtgtcgatgtgaactgc-3 ') PCR verifications are carried out, 2#, 3# transformant fail to expand as wild-type strain WT
Go out the band of 600bp sizes, which is defined as by successful knockout by the ku80 genes of this explanation 2#, 3# transformant
The Aspergillus terreus engineering strain At- Δs ku80 of NHEJ approach missing.
Embodiment 2 builds uracil auxotrophy Aspergillus terreus engineering strain
2.1 structure pyrG target practice elements
According to Aspergillus terreus NIH2624 genome databases announce information design primer UpyrG-F (5 '-
tccatccgatggccattcgtggc-3’)、UpyrG-R(5’-
ctttacgcttgcgatcccgaaaaggtcaattgagacttggacgac-3’)、DpyrG-F1(5’-
tttcgggatcgcaagcgtaaagatgatgagcatgaagaattatgc-3’)、DpyrG-R(5’-
Cgaggtcctaccgatgatgttgc-3 '), using the genome of Aspergillus terreus bacterial strain CICC40205 as template, gathered using pfu DNA
Synthase (Fermentas, Catalog No.:EP0501 PCR amplification) is carried out, can be expanded and obtained with primer UpyrG-F/UpyrG-R
The upstream sequence U-pyrG for the pyrG that size is about 2.5kb is obtained, acquisition size can be expanded with primer DpyrG-F1/DpyrG-R
For the pyrG downstream sequence D-pyrG of 2.5kb, detected through 1.0% agarose gel electrophoresis and carry out being tapped and recovered purifying.With melting
The method for closing PCR is merged U-pyrG fragments with D-pyrG fragments, and using the product of the fusion DNA vaccine as template, with
CpyrG-F (5 '-gtcgtaaatcgttctttgtactg-3 ') and CpyrG-R (5 '-ggaaccccagataatgatacatgc-
3 ') obtain the pyrG that size is about 3kb as primer amplification and knock out element pyrG-KO fragments (Fig. 3).
2.2 protoplast transformations and screening verification
The spore of inoculation said gene engineered strain At- Δs ku80 carries out mycelia training in the IPM fluid nutrient mediums of 50mL
Support, protoplast is prepared with reference to 1.2 described method of above-described embodiment, add 10 μ l at the same time into above-mentioned protoplast suspension
Element pyrG-KO fragments (about 3 μ g) are knocked out, 50 μ l PSTC is added, gently mixes, ice bath 30min.1mL PSTC are added, are mixed
Room temperature places 20min after even, and then (CD+1.2M sorbierite+4g/L agarose+2mM Uridine, go out with 15mL top-layer agars
48 DEG C of insulations after bacterium) (CD tablet+1.2M sorbierites+1g/L on 5 pieces of regeneration screening and culturing medium tablet CDSFU is poured into after mixing
5 ' fluororotic acid+10mM Uridine), cultivated 7 days under 30 DEG C, dark condition.
There to be 5 ' fluororotic acid resistant transformants to be forwarded on screening flat board CDFU (CD tablets+1g/L 5 ' from tablet
Fluororotic acid+10mM Uridine), carry out passage purifying within 7 days in 32 DEG C of cultures, this passage purification experiment is repeated twice.Picking
The transformant grown on CDFU tablets is inoculated on CD tablets, and 32 DEG C are cultivated 7 days.2 plants of transformants are randomly selected to put down in CDFU
Normal growth on plate and be unable on CD tablets normal growth transformant be inoculated in IPMU fluid nutrient mediums (IPM nutrient solutions+
10mM Uridine) in cultivated, collect mycelia extraction genome, with reference to Fig. 3 shown in primer sites progress Genomic PCR test
Card.Carried out with distinctive primer hph-F on primer target practice element and the primer DpyrG-R collocation on the exosome of homology arm
PCR is detected, and as shown in Figure 4 A, two transformants all expand to have obtained the band that size is about 2.5kb, and starting strain At- Δs
Ku80 is then without this band, and there occurs homologous recombination on pyrG sites for this explanation target practice element.As shown in Figure 4 B, with C-F4 (5 '-
Cggatacgtctactccggtaaggc-3 ')/C-R (5 '-agaaactagcgtggagactttgcc-3 ') be primer pair carry out
PCR is detected, and transformant has all amplified the band of size about 1.2kb, and the band that starting strain At- Δs ku80 is expanded is big
Small is 2.1kb, and the pyrG bands that this explanation size is about 0.9kb are knocked.As shown in Figure 4 C, with positioned at pyrG gene internals
Primer pair S-pyrG-F (5 '-actcgcgcccgcacgcacccgaac-3 ')/S-pyrG-R (5 '-
Tccttctggtaccgctggacagc-3 ') PCR detections are carried out, as a result starting strain At- Δs ku80 amplifications have arrived size and have been about
The pyrG bands of 0.8kb, and two transformants all fail to amplify the band, this explanation pyrG gene in the two transformants
Knocked out completely.The uracil auxotrophy Aspergillus terreus engineering strain is denoted as At- Δ ku80- Δs pyrG.
Embodiment 3 establishes the genetic transformation system based on uracil auxotrophy
Target practice element of 3.1 structures using pyrG1 as selection markers
SEQ ID NO.1 are synthesized by gene chemical synthesis mode, which opens including two loxP sites in the same direction, PalcA
Mover and restriction endonuclease sites, the sequence of the synthesis are finally cloned on pUC57simple carriers, obtain carrier
PalcA-syn (Fig. 5).With pyrG1-F (5 '-ctaat gctagc cagcagggaatacgagctcca-3 ')/pyrG-R (5 '-
Ctaat gctagc gcatcaaatcgtcgtaccgc-3 ') primer is used as, carried out by template of aspergillus niger Co827 genomes
PCR amplification, obtains the Expression element that size is about the pyrG genes of 1.5kb aspergillus nigers, as selection markers pyrG1, passes through Nhe
PyrG1 fragments are cloned into PalcA-syn carriers by I restriction enzymes, obtain plasmid pXH103.With primer Sgfp-F1
(5’-gat ccatggtgagcaagggcgaggagc-3’)/TtrpC-R1(5’-gag ctcgag
Ttactattgtatacccatcttag-3 '), with pSGF957 (referring to Jeong-Gu Kim, Yang Do Choi, Yung-Jin
Chang, Soo-Un Kim, Genetic transformation of Monascus purpureus DSM1379,
Biotechnology Letters, 2003,25:1509-1514 structure) it is that template carries out PCR amplification gfp-TtrpC fragments,
The band that size is about 1.3kb is cloned into plasmid pXH103 by Nco I and Xho I restriction enzymes, obtains plasmid
pXH104.With Dw2-ku80-F (5 '-cat ctcgag tccggcctcgatgtggatgc-3 ')/Dw2-ku80-R (5 '-cta
Gaattc tccacgcggccatcaccgagc-3 ') primer is used as, carry out PCR by template of Aspergillus terreus CICC40205 genomes
Amplification, passes through restriction enzyme Xho I and Eco RI gram by the ku80 downstreams homology arm fragment that obtained size is about 1.5kb
In the grand pXH104 to plasmid, plasmid pXH105 is obtained.With Up2-ku80-F (5 '-tca gcggccgc
gtcgtagctcttcttgccatc-3’)/Up2-ku80-R(5’-ctaat gctagc tcaatcaccatctcccttatc-
3 ') primer is used as, PCR amplification is carried out by template of Aspergillus terreus CICC40205 genomes, is about 1.5kb's by obtained size
Ku80 upstreams homology arm fragment, after being carried out digestion with restriction enzyme Not I and Nhe I and recycled, be cloned into through Not I and
In pXH105 carriers after Spe I digestions, plasmid pXH106 is obtained.Cku80-F/Cku80-R is primer, and pXH106 is as mould
Plate, amplification obtain DNA fragmentation that size is about 6.3kb as target practice element ku80-pyrG1-gfp, such as Fig. 6.
3.2 uracil auxotrophy At- Δs ku80- Δs pyrG are tested as the covering of host strain
The spore of said gene engineered strain At- Δ ku80- Δs pyrG is inoculated with the IPMU fluid nutrient mediums (IPM of 50mL
20mM Uridine are supplemented in culture medium) in, 30 DEG C, 200rpm, cultural hypha is carried out, is described with reference to above-described embodiment 1.2
Method prepare protoplast, into above-mentioned protoplast suspension at the same time add 10 μ l knock out element ku80-pyrG1-gfp fragments
(about 3 μ g), adds 50 μ l PSTC, gently mixes, ice bath 30min.1mL PSTC are added, room temperature places 20min after mixing,
Then with being poured into regeneration screening training after top-layer agar (CD+1.2M sorbierite+4g/L agaroses, 48 DEG C of insulations after sterilizing) mixing
Support on base tablet CDS (CD tablet+1.2M sorbierites), cultivated 7 days under 30 DEG C, dark condition.
Obtained transformant is subjected to passage purifying in 5-7 days in 32 DEG C of cultures, this passage purification experiment repeats five times, these
The transformant that growth can be stablized on CD tablets is all to have regained uracil synthesis capability.The primer sites with reference to shown in Fig. 6
Genomic PCR verification is carried out, as shown in the electrophoresis detection result in Fig. 7,6 is obtained and incorporates loxP- in the genome
The positive transformant of pyrG1-loxP selection markers, and these transformants be all in ku80 sites there occurs homologous recombination, this
Illustrate that pyrG1 selection markers are arranged in pairs or groups with uracil auxotrophy Aspergillus terreus bacterial strain At- Δ ku80- Δs pyrG, one can be established
The genetic transformation system of a high homology recombination efficiency.Wherein 1# transformants are denoted as At- Δs ku80-pyrG1-loxP.
4 practical site specific recombination systems of embodiment carry out the excision of selection markers
It is prepared by the protoplast of 4.1 engineering bacteria At- Δs ku80-pyrG1-loxP
For the spore inoculating of picking engineering bacteria At- Δs ku80-pyrG1-loxP in IPM culture mediums, 32 DEG C of culture 14-20 are small
When, the method with reference to described by embodiment 1.2 carries out protoplast preparation after collecting mycelia, and final protoplast is resuspended in STC,
And protoplast concentration is adjusted as 108A/ml.
4.2 are introduced directly into the excision that Cre recombinases carry out selection markers
100ul protoplast solutions are taken, add 2U Cre recombinases (NEB, Catalog No.:M0298L)、1μg
The PEG4000 of pyrG1 fragments and 10 μ l 40%, ice bath 30min after mixing.Add 1ml PSTC solution, 30 DEG C of incubation 30min.
Then with being poured into after top-layer agar (CD+1.2M sorbierite+4g/L agarose+2mM Uridine, 48 DEG C of insulations after sterilizing) mixing
In regeneration screening and culturing medium tablet CDSFU on (5 ' fluororotic acid+10mM Urdine of CD tablet+1.2M sorbierites+1g/L),
30 DEG C, cultivate 6-10 days under dark condition.The transformant switching that picking 27 grows out cultivates 5-7 on CDFU at 32 DEG C
It carries out passage purifying, this passage purification experiment repeats 3-5 times.The transformant that picking is grown on CDFU tablets is inoculated in CD and puts down
On plate, 32 DEG C are cultivated 5-7 days.Randomly select 8 plants on CDFU tablets normal growth and be unable to normal growth on CD tablets
Transformant is inoculated in IPMU fluid nutrient mediums (IPM nutrient solution+10mM Uridine) and is cultivated, and collects mycelia extraction gene
Group, primer U-ku80-F and TtrpC-R carry out Genomic PCR verification with reference to shown in Fig. 8.Can if pyrG1 labels are removed
The fragment that size is 3.3kb is amplified, if pyrG1 fails to cut off, the fragment that size is 4.8kb can be amplified.Such as Fig. 8
Shown, the pyrG1 labels of transformant 1#, 3#, 4#, 6#, 7#, 8# are all cut off completely, by the verification PCR product of 1# transformants
Gene sequencing is sent after middle 3.3kb bands recovery purifying, sequencing primer is S-ku80-F (5 '-ctcctaaacagatataccactc-
3 ') a loxP site (Fig. 9), is left behind between the results show ku80-UP and PalcA, pyrG1 labels are removed really,
The engineered strain is designated as At- Δ ku80- Δs pyrG1-loxP.Found in implementation process, using 10U and 2U Cre recombinases all
Efficiently cutting off and obtain enough positive transformants for selection markers can be realized, in view of cost consideration prioritizing selection uses on a small quantity
Cre recombinases carry out selection markers excision.
Although the present invention is disclosed as above with preferred embodiment, it is not limited to the present invention, any to be familiar with this
The people of technology, is not departing from spirit and scope of the invention, can do various change and modification, therefore, guarantor of the invention
Shield scope should be subject to what claims were defined.
Claims (2)
- A kind of 1. method for cutting off screening label, it is characterised in that be to be incorporated on chromosomepyrGScreen the restructuring of label Bacterium is bacterium germination, is cut off using site-specific recombination systempyrGScreening label enables bacterial strain to use again as going out bacterium germinationpyrGScreen label and carry out genetic transformation；It is described go out bacterium germination, be Aspergillus terreus（Aspergillus terreus）；The chromosome On incorporatepyrGThe recombinant bacterium of label is screened,pyrGThe both sides of screening label also incorporate in the same directionloxPSequence；It is describedpyrG Screening label comes from aspergillus, is carried in the same direction in both sidesloxPSequence；The site-specific recombination system, is Cre/loxPPosition Point specific recombination systems；The excisionpyrGLabel is screened, is that excision both sides carry in the same directionloxPThe screening label of sequencepyrG；The Cre/loxPSite-specific recombination system, the dosage of Cre recombinases is 2-9U；The method, step are as follows：Above-mentioned steps are specific as follows：1) knock out Aspergillus terreus CICC40205's respectivelyku80Gene andpyrGGene, builds uracil auxotrophy recombinant bacterium At-∆ku80-∆pyrG；2) with aspergillus niger Co827'spyrGGene expression elementpyrG1To screen label, and by the method for molecular cloning two Side adds loxP sequences in the same direction, obtains both ends with the same directionloxPSitepyrG1Selection markers loxP-pyrG1-loxP, With step 1）Constructed uracil auxotrophy recombinant bacterium At- ku80- pyrG are recipient bacterium, with loxP-pyrG1- LoxP carries out covering experiment for screening label, obtains the recombinant bacterium At- for being integrated with loxP-pyrG1-loxP screening labels ku80-pyrG1-loxP；3) preparation process 2）The protoplast of gained recombinant bacterium At- ku80-pyrG1-loxP, is assistant carrier to original using DNA The Cre recombinases that 2-9U is imported in raw plastid cell carry out screening label excision, by the side for screening uracil auxotrophy Formula is screenedpyrG1The recombinant bacterium that selection markers are removed.
- 2. claim 1 the method, it is characterised in that be used to prepare and may be repeated screening from screening number of labels limitation Recombinant bacterium.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510275632.3A CN104946688B (en) | 2015-05-26 | 2015-05-26 | A kind of method for cutting off screening label and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510275632.3A CN104946688B (en) | 2015-05-26 | 2015-05-26 | A kind of method for cutting off screening label and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104946688A CN104946688A (en) | 2015-09-30 |
| CN104946688B true CN104946688B (en) | 2018-04-20 |
Family
ID=54161751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510275632.3A Active CN104946688B (en) | 2015-05-26 | 2015-05-26 | A kind of method for cutting off screening label and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104946688B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109666690B (en) * | 2018-02-08 | 2020-05-26 | 南京农业大学 | Method for over-expressing non-trace trichoderma fungus gene |
| CN112111415B (en) * | 2020-09-16 | 2022-10-14 | 福建农林大学 | Method for recycling pyrG screening marker and application |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1423701A (en) * | 1999-11-12 | 2003-06-11 | 洛克菲勒大学 | Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| CN1618961A (en) * | 2003-11-19 | 2005-05-25 | 华中农业大学 | Method capable of auto rejecting marking gene in trans gene plant |
| CN103562391A (en) * | 2011-05-23 | 2014-02-05 | 诺维信公司 | Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi |
-
2015
- 2015-05-26 CN CN201510275632.3A patent/CN104946688B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1423701A (en) * | 1999-11-12 | 2003-06-11 | 洛克菲勒大学 | Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| CN1618961A (en) * | 2003-11-19 | 2005-05-25 | 华中农业大学 | Method capable of auto rejecting marking gene in trans gene plant |
| CN103562391A (en) * | 2011-05-23 | 2014-02-05 | 诺维信公司 | Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi |
Non-Patent Citations (8)
| Title |
|---|
| Consecutive gene deletions in Aspergillus nidulans: application of the Cre/loxP system;Josep V. Forment等;《Curr Genet》;20060617;第50卷;摘要，第217-224页 * |
| Expression and export: recombinant protein production systems for Aspergillus;André Fleißner等;《Appl Microbiol Biotechnol》;20101231;第87卷;第1255-1270页 * |
| Increase in Gene-Targeting Frequencies Due to Disruption of kueA as a ku80 Homolog in Citric Acid-producing Aspergillus niger;Yuki Honda等;《Biosci. Biotechnol.Biochem》;20111231;第75卷(第8期);第1594-1596页 * |
| Nonhomologous end-joining deficiency allows large chromosomal deletions to be produced by replacement-type recombination in Aspergillus oryzae;Tadashi Takahashi等;《Fungal Genetics and Biology》;20091231;第46卷;第815-824页 * |
| Reversible impairment of the ku80 gene by a recyclable marker in Aspergillus aculeatus;Shuji Tani等;《AMB Express》;20131231;第3卷(第4期);第1-8页 * |
| 丝状真菌基因敲除技术研究进展;许杨等;《食品与生物技术学报》;20070131;第26卷(第1期);第123页 * |
| 位点特异性重组***的机理和应用;张霖等;《中国科学》;20101231;第40卷(第12期);第1090-1111页 * |
| 米曲霉pyrG 基因克隆及其同源转化***的建立;王金良等;《食品科学》;20101231;第31卷(第11期);第202-205页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104946688A (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104894165B (en) | A kind of method and application improving gene targeting application efficiency in Aspergillus terreus | |
| CN106480036B (en) | A kind of DNA fragmentation and its application with promoter function | |
| CN107893086A (en) | The method in rapid build pairing sgRNA Cas9 binary expression vectors library | |
| CN103517916B (en) | Filamentous fungi having altered viscosity phenotype | |
| CN110268063A (en) | The method for establishing fungi production bacterial strain using automation genetic manipulation and bacterial strain purification step | |
| Muñoz et al. | Stable transformation of the green algae Acutodesmus obliquus and Neochloris oleoabundans based on E. coli conjugation | |
| CN107365793A (en) | A kind of method of extensive genome editor suitable for plant | |
| CN110257420A (en) | Plant gene silencing carrier and its construction method and application based on CasRx | |
| CN105420154A (en) | Double knockout recombinant rhodococcus as well as construction method and application thereof | |
| CN107603980A (en) | A kind of Kiwi berry Gene A cPDS based on PTG Cas9 edits carrier and its construction method and application | |
| CN104946688B (en) | A kind of method for cutting off screening label and application | |
| CN104711273B (en) | A kind of preparation method and applications of recombinant aspergillus niger glucose oxidase | |
| CN111057654A (en) | Cas9 gene knockout vector applicable to morinda officinalis endophytic fungus A761 and construction method and application thereof | |
| CN103571868A (en) | Transgenic regulation and control miRNA (micro ribonucleic acid) gene algae capable of realizing continuous photosynthetic hydrogen production and creation method of gene algae | |
| CN109486688A (en) | A kind of trichoderma reesei genetic engineering bacterium and its preparation method and application | |
| CN108070609A (en) | By the use of trichoderma reesei as the method for host expresses recombinant protein | |
| CN106191092B (en) | A kind of bacillus polygenes superposition knockout technique | |
| CN107686845A (en) | A kind of rice high efficient conversion carrier pCXUN Cas9 sgRNA and its construction method | |
| CN108603160A (en) | The manufacturing method of mutant filamentous bacterium | |
| CN104894115B (en) | A kind of Aspergillus terreus and its construction method and application with efficient homologous recombination ability | |
| CN105274131B (en) | A kind of method that PEG mediates glue spore anthrax bacteria protoplast genetic transformation | |
| CN102433330A (en) | Recombinant plasmid for genetic transformation of pleurotus eryngii and application thereof | |
| CN113584028B (en) | sgRNA target sequence for gene editing, vector, editing system and application | |
| CN108865901A (en) | One Aspergillus oryzae bacterial strain and its application in aflatoxin degradation | |
| CN105985939B (en) | A kind of its purposes of poly (hydroxyalkanoate) pellet degradation enzyme and (R) -3HB production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20221222 Address after: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Patentee after: Shisenhai (Hangzhou) biopharmaceutical Co.,Ltd. Address before: 266101 Shandong Province, Qingdao city Laoshan District Songling Road No. 189 Patentee before: QINGDAO INSTITUTE OF BIOENERGY AND BIOPROCESS TECHNOLOGY, CHINESE ACADEMY OF SCIENCES |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Patentee after: Zhejiang Boxiao Biopharmaceutical Co.,Ltd. Address before: 311404 standard plant, No. 33, Beishan Road Branch Road, Xindeng Town, Fuyang District, Hangzhou City, Zhejiang Province Patentee before: Shisenhai (Hangzhou) biopharmaceutical Co.,Ltd. |